We developed the “MediC” platform through investigator-generated data, deep learning of biology, pharmacology, medicine, and artificial intelligence to optimize clinical trials and democratize learning about how medical, behavioral and environmental factors may advance or mitigate disease.
Our platform is based on global data with a focus on Korea. Seoul is the primary clinical trial city, but prior to MediC, data was not compiled in a searchable format. Our team uses the open application programming interface (API) in cooperation with the Korean government to collect and integrate data from other countries in other languages.
We are preparing 3 patent cooperation treaty (PCT) applications and 3 Korean technology patents.